Amrita Hospital in Faridabad performed a rare and complex third kidney transplant on Devendra Barlewar, a 47-year-old DRDO ...

The complex four-hour surgery, completed on January 8, 2025, marks a significant advancement in organ transplantation in India. The procedure was made possible after the family of a 50-year-old ...

Dr. Marc Siegel from NYU Langone Health confirmed that a small percentage of vaccinated people suffering from prolonged side ...

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its fourth quarter and year end 2024 ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced participation in a panel discussion at the B. Riley Securities Precision Oncology & Radiopharma Investor Conference that will ...

Biocon share price rose by 2.5% after its arm launched Yesintek, a biosimilar for autoimmune disorders in the US. Approved ...

The study revealed that people with PVS symptoms had lower levels of two types of white blood cells while people with PVS who ...

Devendra Barlewar, a 45-year-old scientist at Defence Research and Development Organisation (DRDO), underwent a four-hour ...

South Korean firm Celltrion announced that the European Commission (EC) has granted marketing authorization for Avtozma ...

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company ...

Researchers analyzed blood samples from 42 participants who reported PVS symptoms and 22 individuals who did not.

Clinical data from Indaptus’ ongoing Phase 1 trial evaluating Decoy20 in advanced solid tumors.